These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 1346982)

  • 1. Catalytic and immunologic similarities between monkey and human liver cytochrome P-450db1 (human cytochrome P-450 2D6).
    Otton SV; Tyndale RF; Wu D; Inaba T; Kalow W; Sellers EM
    Drug Metab Dispos; 1992; 20(1):1-5. PubMed ID: 1346982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human hepatic cytochrome P450 2D6-like activity in nonhuman primates: catalytic characterization in vitro.
    Wu D; Otton SV; Morrow P; Inaba T; Kalow W; Sellers EM
    J Pharmacol Exp Ther; 1993 Aug; 266(2):715-9. PubMed ID: 8355202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes.
    Yamazaki H; Guo Z; Persmark M; Mimura M; Inoue K; Guengerich FP; Shimada T
    Mol Pharmacol; 1994 Sep; 46(3):568-77. PubMed ID: 7935340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of cytochrome P450 2D6-catalyzed sparteine metabolism in humans.
    Ebner T; Meese CO; Eichelbaum M
    Mol Pharmacol; 1995 Dec; 48(6):1078-86. PubMed ID: 8848008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and characterization of a cytochrome P-450 isozyme catalyzing bunitrolol 4-hydroxylation in liver microsomes of male rats.
    Suzuki T; Narimatsu S; Fujita S; Masubuchi Y; Umeda S; Imaoka S; Funae Y
    Drug Metab Dispos; 1992; 20(3):367-73. PubMed ID: 1355709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro evidence against the oxidation of quinidine by the sparteine/debrisoquine monooxygenase of human liver.
    Otton SV; Brinn RU; Gram LF
    Drug Metab Dispos; 1988; 16(1):15-7. PubMed ID: 2894945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of 1,3-, 1,6-, and 1,8-dinitropyrene by cytochrome P-450 enzymes in human and rat liver microsomes.
    Shimada T; Guengerich FP
    Cancer Res; 1990 Apr; 50(7):2036-43. PubMed ID: 2180560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (+)-bufuralol 1'-hydroxylation activity in human and rhesus monkey intestine and liver.
    Prueksaritanont T; Dwyer LM; Cribb AE
    Biochem Pharmacol; 1995 Oct; 50(9):1521-5. PubMed ID: 7503805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuronal cytochrome P450IID1 (debrisoquine/sparteine-type): potent inhibition of activity by (-)-cocaine and nucleotide sequence identity to human hepatic P450 gene CYP2D6.
    Tyndale RF; Sunahara R; Inaba T; Kalow W; Gonzalez FJ; Niznik HB
    Mol Pharmacol; 1991 Jul; 40(1):63-8. PubMed ID: 1857341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human liver microsomal enflurane defluorination catalyzed by cytochrome P-450 2E1.
    Thummel KE; Kharasch ED; Podoll T; Kunze K
    Drug Metab Dispos; 1993; 21(2):350-7. PubMed ID: 8097708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Midazolam and triazolam biotransformation in mouse and human liver microsomes: relative contribution of CYP3A and CYP2C isoforms.
    Perloff MD; von Moltke LL; Court MH; Kotegawa T; Shader RI; Greenblatt DJ
    J Pharmacol Exp Ther; 2000 Feb; 292(2):618-28. PubMed ID: 10640299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative studies of drug-metabolizing enzymes in dog, monkey, and human small intestines, and in Caco-2 cells.
    Prueksaritanont T; Gorham LM; Hochman JH; Tran LO; Vyas KP
    Drug Metab Dispos; 1996 Jun; 24(6):634-42. PubMed ID: 8781778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular cloning, expression, and characterization of CYP2D17 from cynomolgus monkey liver.
    Mankowski DC; Laddison KJ; Christopherson PA; Ekins S; Tweedie DJ; Lawton MP
    Arch Biochem Biophys; 1999 Dec; 372(1):189-96. PubMed ID: 10562433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is N-demethylated by cytochromes P450 2D6, 1A2 and 3A4--implications for susceptibility to Parkinson's disease.
    Coleman T; Ellis SW; Martin IJ; Lennard MS; Tucker GT
    J Pharmacol Exp Ther; 1996 May; 277(2):685-90. PubMed ID: 8627546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipeptide antibodies targeted against specific regions of rat CYP2D1 and human CYP2D6.
    Laurenzana EM; Sorrels SL; Owens SM
    Drug Metab Dispos; 1995 Feb; 23(2):271-8. PubMed ID: 7736924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential activation of cyclophosphamide and ifosphamide by cytochromes P-450 2B and 3A in human liver microsomes.
    Chang TK; Weber GF; Crespi CL; Waxman DJ
    Cancer Res; 1993 Dec; 53(23):5629-37. PubMed ID: 8242617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of human liver cytochrome P450 3A in vinblastine metabolism: drug interactions.
    Zhou-Pan XR; Sérée E; Zhou XJ; Placidi M; Maurel P; Barra Y; Rahmani R
    Cancer Res; 1993 Nov; 53(21):5121-6. PubMed ID: 8221648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type II.
    Zanger UM; Hauri HP; Loeper J; Homberg JC; Meyer UA
    Proc Natl Acad Sci U S A; 1988 Nov; 85(21):8256-60. PubMed ID: 3186722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of bupranolol with the polymorphic debrisoquine/sparteine monooxygenase (CYP2D6).
    Pressacco J; Muller R; Kalow W
    Eur J Clin Pharmacol; 1993; 45(3):261-4. PubMed ID: 8276051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. l-Deprenyl metabolism by the cytochrome P450 system in monkey (Cercopithecus aethiops) liver microsomes.
    Dragoni S; Bellik L; Frosini M; Sgaragli G; Marini S; Gervasi PG; Valoti M
    Xenobiotica; 2003 Feb; 33(2):181-95. PubMed ID: 12623760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.